Innovex International, Inc.
NYSE:INVXOil & Gas Equipment & Services
-$0.92 today
- Market cap
- $1.67B
- Beta
- 0.82
- P/E (TTM)
- 33.5
- EPS (TTM)
- $0.75
Volume 0.46M
Average 0.43M
INVX Operating Cash Flow
Cash generated by the company's core business operations during the period.
Innovex International, Inc.NYSE: INVX
Operating Cash Flow · Q3 FY2026 · quarter ended Sep 2026
Operating cash flow declines year over year
Q3 FY2026 operating cash flow of $38.82M fell 19.8% year over year, behind the -15.5% change in trailing-twelve-month operating cash flow. Sequentially, it rose 4.8% from the prior quarter.
Context
- Operating cash flow amounted to 19.5% of revenue in FY2025, up 5.4 pp from a year earlier.
- Operating cash flow increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -19.8% toward the trailing-twelve-month pace of -15.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 190.91M USD
- Year-over-year change
- +104.3%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 190.91M | +104.3% |
| FY2024 | 2024-12-31 | 93.44M | +23.2% |
| FY2023 | 2023-12-31 | 75.86M | +1405.5% |
| FY2022 | 2022-12-31 | (5.81M) | -187.0% |
| FY2021 | 2021-12-31 | (2.03M) | — |
Operating Cash Flow vs competitors
How INVX compares with its peers on the latest reported figures
- INVX's LTM Sep 2026 operating cash flow of $147.93M is the 8th largest of the 11 companies compared; the peer median is $192.23M.
- Its year-over-year change of -15.5% is the 7th highest of 11, against a peer median of +15.7%.
- Operating cash flow amounts to 14.5% of revenue for INVX, versus a peer median of 13.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $352.96M | +27.3% | +175.0% | 13.8% | |
| LTM Jun 2026 | $343.58M | +35.3% | +64.1% | 41.9% | |
| LTM Sep 2026 | $340.13M | +97.8% | +41.9% | 18.6% | |
| LTM Sep 2026 | $241M | +24.2% | — | 5.0% | |
| LTM Mar 2026 | $193.95M | +7.1% | +37.9% | 12.2% | |
| LTM Mar 2026 | $190.52M | +26.9% | — | 12.5% | |
| LTM Mar 2026 | $164.45M | -22.2% | -14.7% | 85.5% | |
| LTM Sep 2026 | $147.93M | -15.5% | — | 14.5% | |
| LTM Mar 2026 | $143.79M | -31.3% | -17.1% | 13.5% | |
| LTM Mar 2026 | $132.2M | -57.6% | +28.4% | 0.4% | |
| LTM Mar 2026 | $102.85M | -45.3% | -13.6% | 30.3% | |
| Peer median (excluding INVX) | $192.23M | +15.7% | +33.1% | 13.6% | |
Competitors are the stored peer set for INVX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 9.85M | 63.28M | 604K | 140.33M | 83.3M |
| Depreciation & Amortization | 17.74M | 24.96M | 30.06M | 39.52M | 73.24M |
| Deferred Income Tax | (8.7M) | (6.71M) | (7.41M) | (4.6M) | 34.29M |
| Stock-Based Compensation | 703K | 907K | 0 | 13.25M | 13.8M |
| Change in Working Capital | (32.39M) | (79.63M) | (23.81M) | (4.7M) | 19.28M |
| Accounts Receivables | (27.11M) | (37.57M) | (29.08M) | 13.22M | 17.63M |
| Inventory | (13.95M) | (44.21M) | (28.64M) | 7.87M | 46.63M |
| Accounts Payables | 9.57M | 2.41M | 4.21M | (22.34M) | (12.7M) |
| Other Working Capital | (901K) | (265K) | 29.7M | (3.45M) | (32.28M) |
| Other Non-Cash Items | 10.78M | (8.61M) | 76.42M | (90.36M) | (33M) |
| Operating Cash Flow | (2.03M) | (5.81M) | 75.86M | 93.44M | 190.91M |
| Capital Expenditures | (6.44M) | (9.58M) | (15.49M) | (13.59M) | (35.13M) |
| Acquisitions (Net) | (22.2M) | (28.91M) | (53.51M) | 88.79M | (83.67M) |
| Purchases of Investments | 0 | (32.23M) | (48.87M) | 0 | 0 |
| Sales of Investments | 0 | 0 | 55.19M | 0 | 0 |
| Other Investing Activities | 6.58M | 33.2M | 47.39M | 3.25M | 100.06M |
| Investing Cash Flow | (22.06M) | (37.52M) | (32.43M) | 78.44M | (18.74M) |
| Debt Repayment | 10.38M | 44.3M | (44.96M) | (21.18M) | (32.96M) |
| Common Stock Issued | 0 | 0 | 0 | 3.33M | 0 |
| Common Stock Repurchased | (331K) | (1.29M) | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | (74.98M) | 0 |
| Other Financing Activities | 0 | (719K) | 393K | (10.24M) | (11.96M) |
| Financing Cash Flow | 10.05M | 42.29M | (44.57M) | (103.07M) | (44.92M) |
| Effect of Forex Changes | (145K) | (272K) | 118K | (2.94M) | 2.88M |
| Net Change in Cash | (14.18M) | (1.32M) | (1.01M) | 65.87M | 130.13M |
| Free Cash Flow | (8.47M) | (15.39M) | 60.38M | 79.85M | 155.78M |
Innovex International, Inc.
NYSE:INVX
Intrinsic Alpha fair value
Locked
Current Price
$23.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.